| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/17/1999 | WO1999029302A1 Drug delivery system with two-step targeting |
| 06/17/1999 | WO1999024396A8 Ion binding compounds, radionuclide complexes, methods of making radionuclide complexes, methods of extracting radionucleides, and methods of delivering radionuclides to target locations |
| 06/17/1999 | WO1999016477A3 32p-polyphosphazene |
| 06/16/1999 | EP0921843A1 Rhenium radioactive catheter |
| 06/16/1999 | EP0921822A1 Animal model for transplantation |
| 06/16/1999 | EP0921756A1 Novel radiopharmaceutical compositions and matrices and uses thereof |
| 06/16/1999 | EP0757690A4 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 06/15/1999 | US5911971 Nmr contrast media which can mark the vasal space (blood pool agent); uniform and high enough molecular weight to be retained in blood vessel but small enough to be eliminated by the kidney; polyaminoamides; macromolecules |
| 06/15/1999 | US5911970 Antitumor agents and anticarcinogenic agents |
| 06/15/1999 | US5911969 Pretargeting protocols for enhanced localization of active agents to target sites |
| 06/10/1999 | WO1999027967A1 Therapeutic agents |
| 06/09/1999 | EP0920623A1 Boron neutron capture therapy using pre-targeting methods |
| 06/08/1999 | US5910403 Contacting cell with nontoxic stable isotopic label which is incorporated into dna by de novo nucleotide synthesis, detecting amount of label in dna |
| 06/03/1999 | WO1999026551A1 Method to enhance tissue accumulation of radiolabeled compounds |
| 06/02/1999 | EP0918547A2 Radiolabeled annexins |
| 06/02/1999 | EP0918508A1 Improved masking of liposomes from res recognition |
| 06/02/1999 | EP0740581A4 Particulate material |
| 06/02/1999 | CN1218461A Alkylaminobenzothiazole and -benzoxazole derivatives |
| 06/02/1999 | CN1218409A Stimulation of host defence mechanisms against viral challenges |
| 06/02/1999 | CN1217941A Medicinal radiative nuclear element by monoclone antibody of mouse liver cancer |
| 06/01/1999 | US5908931 Preorganized hexadentate ligands useful in radiographic imaging agents |
| 06/01/1999 | US5908757 Diagnosing by measuring complex formation of smooth muscle myosin heavy chain found in blood sample with specific antibodies; detecting increases levels |
| 05/27/1999 | WO1999025666A2 Process for the selective oxidation of organic compounds |
| 05/26/1999 | EP0917464A1 Use of amines to produce drugs for preventing tumour cell proliferation |
| 05/26/1999 | EP0859641A4 Dopamine transporter imaging agent |
| 05/26/1999 | EP0453560B1 Localization and characterization of the wilms' tumor gene |
| 05/26/1999 | CN1217662A Water soluble paclitaxel prodrugs |
| 05/25/1999 | US5906977 Conjugate for treating inflammatory diseases |
| 05/25/1999 | US5906807 Enhanced contrast for nuclear magnetic resonance |
| 05/25/1999 | CA2073431C Interdigitation-fusion liposomes and gels |
| 05/25/1999 | CA1340556C High molecular compound comprising unit of asialoglyco-protein acceptor-directing compound and unit of chelate-forming compound chemically bonded thereto, and its utilization |
| 05/20/1999 | WO1999024396A1 Ion binding compounds, radionuclide complexes, methods of making radionuclide complexes, methods of extracting radionucleides, and methods of delivering radionuclides to target locations |
| 05/20/1999 | WO1999024081A2 A radionuclide-binding compound and its delivery system |
| 05/20/1999 | WO1999024080A1 Para-hydrogen labelled agents and their use in magnetic resonance imaging |
| 05/20/1999 | WO1999024078A1 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells |
| 05/20/1999 | WO1999015665A3 Mutants of thyroid stimulating hormone and methods based thereon |
| 05/20/1999 | WO1999015653A3 Tie ligand homologues |
| 05/20/1999 | WO1999002195A3 Coronary stent with a radioactive, radiopaque coating |
| 05/19/1999 | EP0915974A1 Modified tie-2-receptor ligands |
| 05/19/1999 | EP0915710A2 Stable radioiodine conjugates and methods for their synthesis |
| 05/19/1999 | EP0713513A4 Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes |
| 05/19/1999 | CN1216924A Diagnostic composition |
| 05/14/1999 | WO1999023104A2 Antitumour uridine analogues |
| 05/14/1999 | WO1999022812A1 In situ-generated solid radiation source based on tungsten188/rhenium188 and the use thereof |
| 05/14/1999 | WO1999022775A1 Methods for treating prostate tumors using radioactive compositions |
| 05/14/1999 | WO1999022774A1 Radioactive embolizing compositions |
| 05/14/1999 | WO1999022670A2 In-situ radioactive stent |
| 05/14/1999 | WO1999000150A9 Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor |
| 05/14/1999 | CA2311290A1 In-situ radioactive stent |
| 05/14/1999 | CA2309163A1 In situ-generated solid radiation source based on tungsten188/rhenium188 and the use thereof |
| 05/14/1999 | CA2307191A1 Radioactive embolizing compositions |
| 05/14/1999 | CA2307190A1 Methods for treating prostate tumors using radioactive compositions |
| 05/12/1999 | EP0914155A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 05/12/1999 | EP0914042A1 Cluster clearing agents |
| 05/12/1999 | DE19719098C1 Diagnostic determination of labelled nitric oxide in breath |
| 05/11/1999 | US5902583 Genetic induction of receptors for targeted radiotherapy |
| 05/11/1999 | US5902566 Eluting column with an eluent consisting of acetate buffer solution having a ph of from 4.6 to 5.5 to selectively elute yttrium 90 formed by the decay of the strontium 90 to the cation exchange resin, recovering eluate, labeling protein |
| 05/06/1999 | WO1999021587A1 Complexing agents and targeting immunoreagents |
| 05/06/1999 | WO1999013920A3 Method for treating proliferative diseases by therapy |
| 05/06/1999 | EP0913161A2 Diagnostic agent for diabetes |
| 05/06/1999 | EP0912738A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/06/1999 | EP0912566A1 Pyrrolo 2,3-b]pyridine derivatives, useful as radiolabelled d4 receptor ligands |
| 05/06/1999 | EP0912533A1 Alkylaminobenzothiazole and -benzoxazole derivatives |
| 05/06/1999 | EP0912218A1 TECHNETIUM-99m GENERATOR SYSTEM |
| 05/06/1999 | EP0775104B1 Dimer dtpa derivatives and their metal complexes, pharmaceuticals containing the same, their use in diagnosis and therapy and process for preparing said complexes and pharmaceuticals |
| 05/04/1999 | US5900377 Method for isolating and radiolabeling leukocytes for use in vivo |
| 05/04/1999 | CA1340527C Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 04/29/1999 | WO1999020316A1 Single photon-emitting radiotraces and methods for their use |
| 04/28/1999 | EP0911323A1 Biologically useful conjugates |
| 04/28/1999 | EP0911040A1 Diagnostic agent for liver function |
| 04/28/1999 | EP0910663A1 Methods and compositions for determining the tumor suppressor status of cells |
| 04/28/1999 | EP0910416A2 Radiopharmaceutical compositions capable of localizing at sites of thrombus |
| 04/28/1999 | EP0456766B1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE |
| 04/28/1999 | CN1043143C Beta, beta-dihydroxy meso-substituted chlorin, bacteriochlorin, isobacteriochlorin and process for making same |
| 04/27/1999 | CA2064585C Inhibition of tumor growth by blockade of the protein c system |
| 04/22/1999 | WO1998048852A3 Polymer-coated stents |
| 04/22/1999 | WO1998048851A3 Stents with a radioactive surface coating |
| 04/22/1999 | WO1998048849A9 Radionuclide associated with nucleotide polyphosphate as tumor imaging agents |
| 04/21/1999 | EP0909817A1 Uses of gro genes and proteins |
| 04/21/1999 | EP0692981B1 Chelators of type xn 1?s 1?x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
| 04/21/1999 | EP0692980B1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
| 04/21/1999 | EP0692976B1 Chelating agents of the type xn 1?s 1?o 1? for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy |
| 04/21/1999 | EP0369000B1 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 04/20/1999 | US5895640 Nuclear medicine techniques for detecting carcinoma in the dense breast |
| 04/15/1999 | WO1999018103A1 Dopamine transporter imaging ligand |
| 04/15/1999 | WO1999017812A1 Intra-coronary radiation devices containing ce-144 or ru-106 |
| 04/15/1999 | WO1999017811A1 Enhancement of delivery of radioimaging and radioprotective agents |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | DE19743373A1 ·3··2·P-Polyphosphazen · 3 · · 2 · P-polyphosphazene |
| 04/15/1999 | DE19741694A1 Treatment of proliferative disorders, i.e. atherosclerosis and tumors |
| 04/15/1999 | CA2305754A1 Dopamine transporter imaging ligand |
| 04/15/1999 | CA2305640A1 Intra-coronary radiation devices containing ce-144 or ru-106 |
| 04/15/1999 | CA2305627A1 Enhancement of delivery of radioimaging and radioprotective agents |
| 04/14/1999 | EP0908187A1 Reagent for evaluating a hepatic operation |
| 04/14/1999 | EP0907735A1 Modulators of tissue regeneration |
| 04/14/1999 | EP0907720A1 Combined radiotherapy and immunotherapy to treat cancer |
| 04/14/1999 | EP0550661B1 Uses of gro genes and proteins |
| 04/08/1999 | WO1999016757A1 Contrasting agent for infarct and necrosis imaging |
| 04/08/1999 | WO1999016477A2 32p-polyphosphazene |
| 04/08/1999 | WO1999016474A1 Lipophilic metal complexes for necrosis and infarct imaging |